RhumbLine Advisers
LNAI

RhumbLine Advisers’s Lunai Bioworks LNAI Stock Holding History

RhumbLine Advisers’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,538
Closed -$66.8K – 4243
2025
Q1 		$66.8K Buy
1,538
+126
+9% +$8.06K ﹤0.01% 3502
2024
Q4 		$94.4K Buy
1,412
+778
+123% +$51.6K ﹤0.01% 3490
2024
Q3 		$24.5K Buy
634
+69
+12% +$4.78K ﹤0.01% 3796
2024
Q2 		$79.1K Buy
+565
New +$77K ﹤0.01% 3584
2023
Q3 		– Sell
-69
Closed -$3.13K – 4352
2023
Q2 		$3.13K Sell
69
-312
-82% -$23.9K ﹤0.01% 4158
2023
Q1 		$28K Buy
381
+15
+4% +$1.32K ﹤0.01% 2927
2022
Q4 		$30K Buy
366
+2
+0.5% +$268 ﹤0.01% 2975
2022
Q3 		$53K Buy
364
+5
+1% +$911 ﹤0.01% 3041
2022
Q2 		$55K Buy
+359
New +$164K ﹤0.01% 3058
2021
Q2 		– Sell
-188
Closed -$53K – 3088
2021
Q1 		$53K Buy
188
+1
+0.5% +$294 ﹤0.01% 2974
2020
Q4 		$44K Buy
187
+37
+25% +$9.35K ﹤0.01% 3025
2020
Q3 		$43K Sell
150
-25
-14% -$7.88K ﹤0.01% 2957
2020
Q2 		$59K Buy
+175
New +$52.8K ﹤0.01% 3021

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

RhumbLine Advisers's LNAI Position: Q2 2025 in Review

RhumbLine Advisers sold out of Lunai Bioworks (LNAI) in Q2 2025, closing a stake of 1,538 shares — an estimated $66.8K sold.

RhumbLine Advisers first reported a position in LNAI in Q2 2020 and held it in 13 quarters. The position peaked at $94.4K in Q4 2024. 42 funds tracked by Wall St. Rank hold LNAI as of Q2 2025.

  • RhumbLine Advisers reported no remaining Lunai Bioworks position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 1,538 Lunai Bioworks shares in Q2 2025, an estimated $66.8K.
  • RhumbLine Advisers first reported a position in Lunai Bioworks in Q2 2020 and held it in 13 quarters.
  • RhumbLine Advisers's Lunai Bioworks position peaked at $94.4K in Q4 2024.
  • 42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.